Jove
Visualize
お問い合わせ

関連する概念動画

Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Characterization of fowl adenoviruses isolated between 2007 and 2014 in China.

Veterinary microbiology·2016
関連記事をすべて見る
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

Updated: Jun 14, 2026

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

16.9K

食道がんの新補助療法における単細胞配列化の適用における進展

Sang Houyi1, Sun Zhiqiang1, Wang Jianlin1

  • 1Department of Radiotherapy, The Affiliated Changzhou Second People's Hospital of Nanjing Medical University, Changzhou, CHN.

Cureus
|September 2, 2025
PubMed
まとめ

単細胞シーケンシング (sc-seq) は食道がんの高解像度トランスクリプトーム分析を提供し,腫瘍のサブタイプ化と治療に役立ちます. この技術は腫瘍の微小環境を理解し,ネオアジュバント療法 (NAT) の結果を改善するために不可欠です.

キーワード:
食道がんネオアジュバント療法sc-seq について腫瘍腫瘍の微小環境 (TME)

さらに関連する動画

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.2K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

528

関連する実験動画

Last Updated: Jun 14, 2026

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing
11:11

Detection of Rare Mutations in CtDNA Using Next Generation Sequencing

Published on: August 24, 2017

16.9K
Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer
07:59

Author Spotlight: Advancements in Molecular Biomarker Testing for Non-Squamous Non-Small Cell Lung Cancer

Published on: September 8, 2023

1.2K
Development of Compendium for Esophageal Squamous Cell Carcinoma
03:36

Development of Compendium for Esophageal Squamous Cell Carcinoma

Published on: April 12, 2024

528

科学分野:

  • 腫瘍学
  • ゲノミクス
  • バイオ情報学

背景:

  • シングルセルシーケンシング (sc-seq) 技術は,個々の細胞レベルで高通量,高解像度のトランスクリプトーム分析を提供します.
  • これにより,細胞集団内の遺伝子発現の違いと分子特性を特定することができます.
  • 食道がんの新補助療法 (NAT) は進歩していますが,患者のアウトカムと再発の減少には課題があります.

研究 の 目的:

  • sc-seq技術の利点とデメリットを探る
  • 食道がん腫瘍の微小環境 (TME) でsc-seqの適用を検証する.
  • 食道がんの様々なNAT療法におけるsc-seqの適用を検討する.

主な方法:

  • sc-seqに関する既存の研究の文献レビューと分析.
  • 食道がんのTMEの特徴化におけるsc-seqの役割の検討.
  • 異なる NAT 戦略の評価における sc-seq の有用性の評価

主要な成果:

  • Sc-seqは,腫瘍の分子サブタイプと治療戦略を決定するための正確なガイドラインを提供します.
  • この技術は,治療反応を理解するために重要な遺伝子発現の異質性を明らかにします.
  • TMEとNATの治療法の適用は,治療の有効性についての洞察を提供します.

結論:

  • Sc-seqは 食道がんの研究と治療を進めるための強力なツールです
  • sc-seqを介してTMEを理解すると,NATの有効性を最適化できます.
  • この技術は,食道腫瘍における新しいネオアジュバント治療戦略の基礎となる.